Navigation Links
NephCure Foundation Announces Research Grant Program Recipients
Date:7/28/2009

Seven applicants receive a total of over $1.7 million

BERWYN, Pa., July 28 /PRNewswire-USNewswire/ -- The NephCure Foundation (NCF) has awarded more than $1.7 million to researchers in its 2009 Scientific Research Grant Program.

The announcement was made by Henry Brehm, NephCure Foundation's Executive Director and Dr. Lawrence Holzman, Chair of the NCF Scientific Advisory Board.

The Scientific Grant Program supports basic, transitional and clinical research initiatives to understand the cause, identify treatments and find the cure for primary focal segmental glomerulosclerosis (FSGS) and Nephrotic Syndrome (NS). To date, The NephCure Foundation has committed over $6 million to research and education, including $1.6 million for the 2008 Scientific Research Grant Program.

Post-Doctoral Fellowship grants were awarded to:

  • Sebastian Martini, M.D. of University of Michigan, Ann Arbor, MI
  • Hideki Kato, M.D., Ph.D. of Albert Einstein College of Medicine, Bronx, NY

Young Investigator Grants were awarded to:

  • Christian Faul, Ph.D. of University of Miami, Miami, FL
  • Valerie Anne Schumacher, Ph.D. of Children's Hospital Boston, Boston, MA
  • Kirk Campbell M.D. of University of Miami, Miami, FL
  • Mira Krendel, Ph.D. of SUNY Upstate Medical University, Syracuse, NY

Established Investigator New Direction Grant awarded to:

  • Sanja Sever, Ph.D. of Massachusetts General Hospital, Boston, MA

The NephCure Foundation launched the grant program in 2008, providing funding for basic, translational and clinical research into two potentially devastating kidney conditions, FSGS and NS. Since the inaugural year, the program has seen nearly a 150 percent increase in the number of applications received. This is indicative of NephCure's growth and increasing role as the leading advocate for research into NS and FSGS.

NS and FSGS are conditions that affect the tiny filtering units (glomeruli) in the kidney. The result is that protein needed by the body is discarded into the urine. Over time, these conditions can result in renal failure and the need for dialysis or a kidney transplant. The primary cause for most forms of NS and FSGS are not known and there is no cure.

The NephCure Foundation has a unique challenge in identifying patient families. Privacy laws preclude doctors from providing information and because FSGS and NS are invisible, people tend to struggle with them silently. Therefore, NephCure uses publicity and public service announcements to find people suffering from the diseases.


'/>"/>
SOURCE NephCure Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
2. Dr. Christopher Olivia Appointed to Foundation Radiology Group Board of Directors
3. Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week
4. Foundation Radiology Group Builds Sales and Marketing Teams for Projected Record-Year Growth
5. National Science Foundation Announces $20M Research Award to South Carolina
6. Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinsons Drug Development
7. The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers
8. The Maurer Foundation for Breast Health Education Launches Integrated Rebranding Operation
9. American Health Assistance Foundation & Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Project
10. TCS Healthcare Technologies Provides $5,000 Seed Money to Help Fund New CMSA Foundation
11. Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St. Louis, Mo.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... Prophecy concerning this present generation. Yisrayl makes an astounding statement when he says ... He explains that the Bible details the current times so plainly that anyone should ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will return to the La Gorce Country Club in Miami Beach to host ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce ... of Pharma To Market Pte Ltd, based in Singapore ... their expansion into Asia with the opening ... are delighted to appoint Joelle Chia , former owner of ... based entity. Joelle brings with her an extensive business network throughout ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
Breaking Medicine Technology: